Investment Analysts’ Price Target Changes for October 30th (AEM, AGCO, AIN, ALHC, ALRM, APG, ARES, ATEC, AU, AVY)

Investment Analysts’ price target changes for Friday, October 30th:

Agnico Eagle Mines (NYSE:AEM) (TSE:AEM) had its price target raised by JPMorgan Chase & Co. from $190.00 to $193.00. The firm currently has a neutral rating on the stock.

AGCO (NYSE:AGCO) had its target price increased by JPMorgan Chase & Co. from $140.00 to $145.00. The firm currently has an overweight rating on the stock.

Albany International (NYSE:AIN) had its price target increased by JPMorgan Chase & Co. from $67.00 to $71.00. The firm currently has a neutral rating on the stock.

Alignment Healthcare (NASDAQ:ALHC) had its price target reduced by JPMorgan Chase & Co. from $10.00 to $8.00. They currently have an overweight rating on the stock.

Alarm.com (NASDAQ:ALRM) had its price target boosted by JPMorgan Chase & Co. from $40.00 to $50.00. They currently have an underweight rating on the stock.

APi Group (NYSE:APG) had its price target increased by JPMorgan Chase & Co. from $50.00 to $55.00. The firm currently has an overweight rating on the stock.

Ares Management (NYSE:ARES) had its price target lowered by JPMorgan Chase & Co. from $155.00 to $154.00. The firm currently has an overweight rating on the stock.

Alphatec (NASDAQ:ATEC) had its target price cut by JPMorgan Chase & Co. from $16.00 to $15.00. The firm currently has an overweight rating on the stock.

AngloGold Ashanti (NYSE:AU) had its target price lowered by JPMorgan Chase & Co. from $139.00 to $138.00. The firm currently has an overweight rating on the stock.

Avery Dennison (NYSE:AVY) had its price target raised by JPMorgan Chase & Co. from $190.00 to $200.00. They currently have an overweight rating on the stock.

Axalta Coating Systems (NYSE:AXTA) had its target price raised by JPMorgan Chase & Co. from $33.00 to $34.00. JPMorgan Chase & Co. currently has a neutral rating on the stock.

Bank of America (NYSE:BAC) had its target price trimmed by JPMorgan Chase & Co. from $62.00 to $59.50. The firm currently has an overweight rating on the stock.

Bel Fuse (NASDAQ:BELFB) had its target price raised by JPMorgan Chase & Co. from $330.00 to $360.00. The firm currently has an overweight rating on the stock.

Bank of New York Mellon (NYSE:BNY) had its price target raised by JPMorgan Chase & Co. from $161.00 to $166.50. JPMorgan Chase & Co. currently has an overweight rating on the stock.

Citigroup (NYSE:C) had its price target boosted by JPMorgan Chase & Co. from $147.00 to $148.50. JPMorgan Chase & Co. currently has an overweight rating on the stock.

Churchill Downs (NASDAQ:CHDN) had its target price raised by JPMorgan Chase & Co. from $118.00 to $120.00. The firm currently has an overweight rating on the stock.

DXC Technology (NYSE:DXC) had its price target raised by JPMorgan Chase & Co. from $12.00 to $13.00. They currently have an underweight rating on the stock.

DexCom (NASDAQ:DXCM) had its price target boosted by JPMorgan Chase & Co. from $82.00 to $85.00. The firm currently has a neutral rating on the stock.

Exponent (NASDAQ:EXPO) had its price target increased by JPMorgan Chase & Co. from $90.00 to $100.00. The firm currently has an overweight rating on the stock.

FedEx Freight (NYSE:FDXF) had its price target increased by JPMorgan Chase & Co. from $149.00 to $151.00. JPMorgan Chase & Co. currently has an overweight rating on the stock.

Fifth Third Bancorp (NASDAQ:FITB) had its price target increased by JPMorgan Chase & Co. from $58.00 to $60.00. The firm currently has an overweight rating on the stock.

Forbright (NASDAQ:FRBT) had its price target raised by JPMorgan Chase & Co. from $22.00 to $23.00. They currently have an overweight rating on the stock.

Grid Dynamics (NASDAQ:GDYN) had its target price raised by JPMorgan Chase & Co. from $8.00 to $11.00. JPMorgan Chase & Co. currently has an overweight rating on the stock.

Gilead Sciences (NASDAQ:GILD) had its price target raised by JPMorgan Chase & Co. from $170.00 to $190.00. The firm currently has an overweight rating on the stock.

Huntington Bancshares (NASDAQ:HBAN) had its target price boosted by JPMorgan Chase & Co. from $17.50 to $18.00. The firm currently has an overweight rating on the stock.

KeyCorp (NYSE:KEY) had its target price boosted by JPMorgan Chase & Co. from $23.00 to $23.50. The firm currently has a neutral rating on the stock.

Kiniksa Pharmaceuticals International (NASDAQ:KNSA) had its price target raised by JPMorgan Chase & Co. from $107.00 to $122.00. They currently have an overweight rating on the stock.

Eli Lilly and Company (NYSE:LLY) had its target price boosted by JPMorgan Chase & Co. from $1,500.00 to $1,650.00. They currently have an overweight rating on the stock.

Mastercard (NYSE:MA) had its price target increased by JPMorgan Chase & Co. from $720.00 to $755.00. They currently have an overweight rating on the stock.

Merit Medical Systems (NASDAQ:MMSI) had its price target boosted by JPMorgan Chase & Co. from $95.00 to $110.00. The firm currently has an overweight rating on the stock.

Merck & Co., Inc. (NYSE:MRK) had its target price raised by JPMorgan Chase & Co. from $165.00 to $175.00. They currently have an overweight rating on the stock.

Oshkosh (NYSE:OSK) had its price target boosted by JPMorgan Chase & Co. from $132.00 to $145.00. JPMorgan Chase & Co. currently has a neutral rating on the stock.

The PNC Financial Services Group (NYSE:PNC) had its target price raised by JPMorgan Chase & Co. from $258.00 to $259.00. JPMorgan Chase & Co. currently has an overweight rating on the stock.

Regeneron Pharmaceuticals (NASDAQ:REGN) had its price target increased by Citigroup from $740.00 to $825.00. Citigroup currently has a neutral rating on the stock.

Regions Financial (NYSE:RF) had its target price increased by JPMorgan Chase & Co. from $30.50 to $31.00. They currently have a neutral rating on the stock.

Rocket Companies (NYSE:RKT) had its target price increased by JPMorgan Chase & Co. from $12.50 to $13.00. The firm currently has a neutral rating on the stock.

Republic Services (NYSE:RSG) had its target price boosted by JPMorgan Chase & Co. from $245.00 to $265.00. The firm currently has a neutral rating on the stock.

Saia (NASDAQ:SAIA) had its price target boosted by JPMorgan Chase & Co. from $463.00 to $468.00. JPMorgan Chase & Co. currently has an overweight rating on the stock.

State Street (NYSE:STT) had its target price raised by JPMorgan Chase & Co. from $187.50 to $192.50. JPMorgan Chase & Co. currently has a neutral rating on the stock.

TAL Education Group (NYSE:TAL) had its target price raised by JPMorgan Chase & Co. from $16.00 to $16.50. JPMorgan Chase & Co. currently has an overweight rating on the stock.

Teladoc Health (NYSE:TDOC) had its price target raised by JPMorgan Chase & Co. from $8.00 to $10.00. The firm currently has a neutral rating on the stock.

Teck Resources (NYSE:TECK) (TSE:TECK) had its price target boosted by JPMorgan Chase & Co. from $47.00 to $63.00. JPMorgan Chase & Co. currently has a neutral rating on the stock.

Truist Financial (NYSE:TFC) had its price target boosted by JPMorgan Chase & Co. from $50.50 to $51.50. They currently have an underweight rating on the stock.

T. Rowe Price Group (NASDAQ:TROW) had its price target raised by JPMorgan Chase & Co. from $106.00 to $107.00. They currently have an underweight rating on the stock.

U.S. Bancorp (NYSE:USB) had its target price increased by JPMorgan Chase & Co. from $65.00 to $65.50. They currently have a neutral rating on the stock.

Wells Fargo & Company (NYSE:WFC) had its price target increased by JPMorgan Chase & Co. from $91.50 to $92.00. JPMorgan Chase & Co. currently has a neutral rating on the stock.

XPO (NYSE:XPO) had its target price boosted by JPMorgan Chase & Co. from $205.00 to $207.00. They currently have an overweight rating on the stock.